{"id":334003,"date":"2026-10-31T00:01:00","date_gmt":"2026-10-30T18:31:00","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/corona-remedies-q2-results-fy27-pat-60-crore\/"},"modified":"2026-10-31T00:01:00","modified_gmt":"2026-10-30T18:31:00","slug":"corona-remedies-q2-results-fy27-pat-60-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/corona-remedies-q2-results-fy27-pat-60-crore\/","title":{"rendered":"CORONA Remedies Q2 Results FY27: Revenue Jumps 22.16% to Rs 441.17 Cr, PAT Rs 60.31 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

CORONA Remedies Q2 Results FY27 were declared on 30 October 2026, and the Consolidated quarterly results show revenue of Rs 441.17 Cr, a YoY growth of 22.16% on Rs 361.13 Cr. Net profit rose 15.27% to Rs 60.31 Cr from Rs 52.32 Cr. Operating Profit was Rs 95.95 Cr, up 22.28% YoY from Rs 78.47 Cr.<\/p>\n<\/div>\n

CORONA Remedies Ltd<\/a> (CORONA) Q2 Results FY27 announced on 30 October 2026, covering the company’s financial performance for the July to September quarter. Revenue totalled Rs 441.17 Cr and PAT Rs 60.31 Cr. The CORONA Remedies Q2 Results FY27 filing sets the results date and the consolidated results side by side for the quarter.<\/p>\n

The CORONA Remedies Q2 Results results analysis that follows looks at the financial highlights, the disclosed business drivers, the FY27 outlook and the risks. Univest starts it with the Financial Highlights table, which places the consolidated numbers against the quarter a year earlier.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n